Key facts
- Axiles Bionics’s last known valuation is $34.5M (Jun 2025).
- It has raised $11.7M; the latest was Later Stage VC ($8.4M) in Jun 2025.
- Notable investors include European Innovation Council, Finance&Invest.Brussels, European Innovation Council (Belgium), PE Group, RobotUnion — 7 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 7 names
- ·Watchlist + deal alerts for Axiles Bionics
- ·The full record, as it builds
Funding rounds
No funding rounds for Axiles Bionics are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Axiles Bionics
Developer of robotic prosthesis technology designed to improve the quality of life for people with amputations. The company's prosthesis offers a unique combination of human ankle strength and flexibility, along with robotic features, enabling people with limb disorders to benefit from smart robotic ankle-foot prostheses that provide improved movement and support.
- Sector
- Healthcare
- HQ
- Brussels, Belgium
- Founded
- 2018
- Employees
- 23
- Website
- axilesbionics.com/
- Ownership
- Privately Held (backing)
Axiles Bionics doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Axiles Bionics shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Axiles Bionics in its N-PORT filings yet. We sweep new filings monthly.